<DOC>
	<DOCNO>NCT02740413</DOCNO>
	<brief_summary>The overall aim study describe demographic clinical characteristic , treatment pattern outcomes , population hemophilia patient treat BeneFIX ReFacto/ReFacto AF Sweden</brief_summary>
	<brief_title>Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study</brief_title>
	<detailed_description>The overall aim study describe demographic clinical characteristic , treatment pattern outcomes , well related direct treatment cost population hemophilia patient treat BeneFIX ReFacto/ReFacto AF , subgroup ( e.g . level severity ) MHC Sweden . The study population consist patient diagnose haemophilia ( D66.9 ( haemophilia A ) D67.9 ( haemophilia B ) International Statistical Classification Diseases Related Health Problems ( ICD-10 ) register MHR since 1977 least one registered prescription BeneFIX ReFacto/ReFacto AF MHR since market authorization respective product ( Benefix August 27 1997 , ReFacto April 13 1999 , ReFacto AF July 1 2009 ) . Diseased individual include . Information drug pick pharmacy available Prescribed Drug Register 2005 .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>The study population consist patient diagnose hemophilia ( D66.9 ( hemophilia A ) D67.9 ( hemophilia B ) International Statistical Classification Diseases Related Health Problems ( ICD10 ) register Malm√∂ Hemophilia Register since 1977 least one registered prescription BeneFIX ReFacto/ReFacto AF MHR since market authorization respective product No exclusion criterion study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>